These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 24628444)

  • 1. Curcumin ameliorates autoimmune diabetes. Evidence in accelerated murine models of type 1 diabetes.
    Castro CN; Barcala Tabarrozzi AE; Winnewisser J; Gimeno ML; Antunica Noguerol M; Liberman AC; Paz DA; Dewey RA; Perone MJ
    Clin Exp Immunol; 2014 Jul; 177(1):149-60. PubMed ID: 24628444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antidiabetic and Immunoregulatory Activities of Extract of
    Lin CH; Kuo YH; Shih CC
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paralytic autoimmune myositis develops in nonobese diabetic mice made Th1 cytokine-deficient by expression of an IFN-gamma receptor beta-chain transgene.
    Serreze DV; Pierce MA; Post CM; Chapman HD; Savage H; Bronson RT; Rothman PB; Cox GA
    J Immunol; 2003 Mar; 170(5):2742-9. PubMed ID: 12594305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-bet-deficient NOD mice are protected from diabetes due to defects in both T cell and innate immune system function.
    Esensten JH; Lee MR; Glimcher LH; Bluestone JA
    J Immunol; 2009 Jul; 183(1):75-82. PubMed ID: 19535634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-12 administration accelerates autoimmune diabetes in both wild-type and IFN-gamma-deficient nonobese diabetic mice, revealing pathogenic and protective effects of IL-12-induced IFN-gamma.
    Trembleau S; Penna G; Gregori S; Giarratana N; Adorini L
    J Immunol; 2003 Jun; 170(11):5491-501. PubMed ID: 12759426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CXCR4/CXCL12 (SDF-1) signalling pathway protects non-obese diabetic mouse from autoimmune diabetes.
    Aboumrad E; Madec AM; Thivolet C
    Clin Exp Immunol; 2007 Jun; 148(3):432-9. PubMed ID: 17374136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated NF-kappaB activation in nonobese diabetic mouse dendritic cells results in enhanced APC function.
    Poligone B; Weaver DJ; Sen P; Baldwin AS; Tisch R
    J Immunol; 2002 Jan; 168(1):188-96. PubMed ID: 11751962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
    Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
    Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice.
    Bending D; De la Peña H; Veldhoen M; Phillips JM; Uyttenhove C; Stockinger B; Cooke A
    J Clin Invest; 2009 Mar; 119(3):565-72. PubMed ID: 19188681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.
    Tian J; Zekzer D; Hanssen L; Lu Y; Olcott A; Kaufman DL
    J Immunol; 2001 Jul; 167(2):1081-9. PubMed ID: 11441119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.
    Mukherjee R; Chaturvedi P; Qin HY; Singh B
    J Autoimmun; 2003 Nov; 21(3):221-37. PubMed ID: 14599847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-12 administration reveals diabetogenic T cells in genetically resistant I-Ealpha-transgenic nonobese diabetic mice: resistance to autoimmune diabetes is associated with binding of Ealpha-derived peptides to the I-A(g7) molecule.
    Trembleau S; Gregori S; Penna G; Gorny I; Adorini L
    J Immunol; 2001 Oct; 167(7):4104-14. PubMed ID: 11564833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse.
    Stephens LA; Kay TW
    Int Immunol; 1995 Dec; 7(12):1885-95. PubMed ID: 8746558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B lymphocyte-induced maturation protein 1 (BLIMP-1) attenuates autoimmune diabetes in NOD mice by suppressing Th1 and Th17 cells.
    Lin MH; Chou FC; Yeh LT; Fu SH; Chiou HY; Lin KI; Chang DM; Sytwu HK
    Diabetologia; 2013 Jan; 56(1):136-46. PubMed ID: 23052053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ectopic PDX-1 expression in liver ameliorates type 1 diabetes.
    Shternhall-Ron K; Quintana FJ; Perl S; Meivar-Levy I; Barshack I; Cohen IR; Ferber S
    J Autoimmun; 2007; 28(2-3):134-42. PubMed ID: 17383157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAK1 inhibition prevents the development of autoimmune diabetes in NOD mice.
    Cao H; Lu J; Du J; Xia F; Wei S; Liu X; Liu T; Liu Y; Xiang M
    Sci Rep; 2015 Oct; 5():14593. PubMed ID: 26459028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-15 plays an essential role in the pathogenesis of autoimmune diabetes in the NOD mouse.
    Bobbala D; Chen XL; Leblanc C; Mayhue M; Stankova J; Tanaka T; Chen YG; Ilangumaran S; Ramanathan S
    Diabetologia; 2012 Nov; 55(11):3010-20. PubMed ID: 22890824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of T helper 1 and T helper 2 immune balance in a murine stress model during Chlamydia muridarum genital infection.
    Belay T; Martin E; Brown G; Crenshaw R; Street J; Freeman A; Musick S; Kinder TJ
    PLoS One; 2020; 15(5):e0226539. PubMed ID: 32413046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New DiaP277 analogue shifts DCs to tolerogenic, and modulates NF-Kβ1 to suppress autoreactive T lymphocytes in the type 1 diabetic mice.
    Alahdal M; Liangliang J; Shiping L; Yun X; Gao H; Jialei Z; Hassan W; Jin L; Rongyue C
    Autoimmunity; 2018 Aug; 51(5):210-220. PubMed ID: 30382756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice.
    Funda DP; Goliáš J; Hudcovic T; Kozáková H; Špíšek R; Palová-Jelínková L
    Front Immunol; 2018; 9():290. PubMed ID: 29503651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.